Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe 3D Cell Culture Market, by Type
1.4.2 Europe 3D Cell Culture Market, by Application
1.4.3 Europe 3D Cell Culture Market, by End User
1.4.4 Europe 3D Cell Culture Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, May – 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2022, Jun) Leading Players
Chapter 4. Europe 3D Cell Culture Market by Type
4.1 Europe Scaffold-based Market by Country
4.2 Europe Scaffold-free Market by Country
4.3 Europe Microfluidics-based Market by Country
4.4 Europe Magnetic & Bioprinted Market by Country
Chapter 5. Europe 3D Cell Culture Market by Application
5.1 Europe Cancer & Stem Cell Research Market by Country
5.2 Europe Drug Discovery & Toxicology Testing Market by Country
5.3 Europe Tissue Engineering & Regenerative Medicine Market by Country
Chapter 6. Europe 3D Cell Culture Market by End User
6.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.2 Europe Research Institutes Market by Country
6.3 Europe Cosmetic Industry Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe 3D Cell Culture Market by Country
7.1 Germany 3D Cell Culture Market
7.1.1 Germany 3D Cell Culture Market by Type
7.1.2 Germany 3D Cell Culture Market by Application
7.1.3 Germany 3D Cell Culture Market by End User
7.2 UK 3D Cell Culture Market
7.2.1 UK 3D Cell Culture Market by Type
7.2.2 UK 3D Cell Culture Market by Application
7.2.3 UK 3D Cell Culture Market by End User
7.3 France 3D Cell Culture Market
7.3.1 France 3D Cell Culture Market by Type
7.3.2 France 3D Cell Culture Market by Application
7.3.3 France 3D Cell Culture Market by End User
7.4 Russia 3D Cell Culture Market
7.4.1 Russia 3D Cell Culture Market by Type
7.4.2 Russia 3D Cell Culture Market by Application
7.4.3 Russia 3D Cell Culture Market by End User
7.5 Spain 3D Cell Culture Market
7.5.1 Spain 3D Cell Culture Market by Type
7.5.2 Spain 3D Cell Culture Market by Application
7.5.3 Spain 3D Cell Culture Market by End User
7.6 Italy 3D Cell Culture Market
7.6.1 Italy 3D Cell Culture Market by Type
7.6.2 Italy 3D Cell Culture Market by Application
7.6.3 Italy 3D Cell Culture Market by End User
7.7 Rest of Europe 3D Cell Culture Market
7.7.1 Rest of Europe 3D Cell Culture Market by Type
7.7.2 Rest of Europe 3D Cell Culture Market by Application
7.7.3 Rest of Europe 3D Cell Culture Market by End User
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Geographical Expansions:
8.2 Merck Group
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Avantor, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.3.4.2 Acquisition and Mergers:
8.4 Corning Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Lonza Group AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Geographical Expansions:
8.6 Mimetas B.V.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.7 Insphero AG
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Emulate, Inc.
8.8.1 Company Overview
8.9 Tecan Group Ltd.
8.9.1 Company Overview
8.10. CN Bio Innovations Ltd.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
8.10.2.3 Geographical Expansions:
Unique Offerings 